Computer-assisted hair restoration using the ARTAS system

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of the ARTAS System for hair restoration in men suffering from androgenic alopecia. It involves a prospective, multi-center approach across up to four investigational centers. Participants will undergo hair restoration procedures with the ARTAS technology, which utilizes advanced robotics for harvesting and implantation. The study aims to assess the performance and outcomes of this innovative method in treating hair loss.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subject is male with clinical diagnosis of androgenetic alopecia with Norwood-Hamilton grade of III-VI
* Subject is 20 to 70 years old
* Subject agrees to cut hair short (\< 1 mm) on the scalp in the designated study areas for harvesting and implantation
* Subject is able to understand and provide written consent
* Subject consents to post-operative follow-up per protocol

Exclusion Criteria:

* Subject has prior history of scalp reduction surgery(s) in the past six months
* Subject has bleeding diathesis
* Subject has active use of anti-coagulation medication
* Subject has any other condition that, in the opinion of the investigator, makes the subject inappropriate to take part in this study

Where it's running

• Le's Aesthetics
  San Jose, California, United States Recruiting
• Berman Skin Institute
  Los Altos, California, United States Completed

Study contacts

• Study coordinator: Director of Clinical Affairs, PhD
• Email: mgronski@venusconcept.com
• Phone: 8889070115

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Dual treatment with KeraFactor and Revian LED for female pattern hair loss

  This study tests whether using a scalp-stimulating serum together with a Revian LED cap helps women with androgenic alopecia grow more hair than each treatment alone or placebo.

  Recruiting K. Kay Durairaj, MD, FACS, A Medical Corporation · Pasadena, California · NCT07810504

• Two hair supplements for men with androgenic alopecia

  This study tests two daily hair supplement formulations against placebo to see if they improve hair growth and perceived hair quality in men with mild to moderate androgenetic alopecia over 84 days.

  Recruiting at 6 sites Activ'inside · Rende, Cosenza and 5 other locations · NCT07806474

• JAK2 levels in balding and non-balding scalp before and after topical minoxidil

  This will test whether three months of topical minoxidil changes JAK2 protein levels in the scalps of adults (18–50) with mild to moderate androgenetic alopecia.

  Recruiting Kasr El Aini Hospital · Cairo, Cairo Governorate · NCT07563036

• 2-Deoxy-D-ribose hydrogel versus 5% minoxidil for androgenetic alopecia

  This trial will test whether a once-daily topical 2‑Deoxy‑D‑ribose hydrogel is as effective and safe as 5% minoxidil for adults aged 18 to 50 with mild to moderate androgenetic alopecia.

  Recruiting Kasr El Aini Hospital · Cairo, Cairo Governorate · NCT07502976

• TH07 topical treatment for male pattern hair loss

  This trial will test whether a new daily topical spray called TH07 helps men aged 18–49 with male pattern hair loss grow more hair than standard minoxidil or a placebo over 24 weeks.

  Recruiting Phase 3 Triple Hair Inc · Vancouver, British Columbia · NCT07435012

• Umbilical cord mesenchymal stem cell exosome treatment for male pattern hair loss in young men

  This trial will test whether injections of umbilical cord mesenchymal stem cell exosomes can regrow hair or slow hair loss in men aged 18–35 with androgenic alopecia compared with topical 5% minoxidil.

  Recruiting Phase 1/2 Shenzhen People's Hospital · Shenzhen, Guangdong · NCT07203599

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.